According to our recent payer coverage analysis for type 2 diabetes treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.
To help make sense of this new research, MMIT’s team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.
Payer Coverage: A review of market access for type 2 diabetes treatments shows that almost half of the lives under the commercial and health exchange formularies have utilization management restrictions.
Trends: Health insurers are targeting diabetes via prevention programs and technology. Via AIS Health.